Conference abstract · 27 Oct 2015
Conference abstractPublished 1 Sep 2015
The potential effect of Caffeine and Nicotine co-administration on the induction of Alzheimer’s disease
Al-Azhar University, Egypt
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Alzheimer’s disease (AD) is a progressive neurodegenerative disease characterized clinically by memory impairment and other cognitive problems. Caff eine and nicotine are the most commonly co-used psychostimulants. Caff eine is one of the major contributors to the dietary antioxidants which prevent oxidative damage and may reduce the risk of chronic neurodegenerative diseases. Nicotine has the ability to decrease level of ROS in the hippocampus and suggested to attenuate the impairment of memory associated with AD. Th e purpose of the study was to evaluate the infl uence of caff eine and nicotine co-administration against aluminium-induced AD in rats. Five groups of rats were used and received daily for fi ve weeks: Saline for control group, ALCl3 (70mg/kg, IP) for AD group, while treated groups received together with ALCl3, either Caff eine (5mg/kg, IP), Nicotine (1mg/kg, SC) or both Caff eine and Nicotine. Th ree behavioral experiments were performed: Forced swimming test, Morris water maze task and Conditioned-avoidance and learning test. Histopathological changes in the brain and biochemical changes in Acetyl cholinesterase (ACHE) as well as oxidative parameters; (MDA, SOD, TAC) were also evaluated for all groups. Results of the behavioral tests showed that caff eine and nicotine co-administration had more pronounced protecting eff ect from learning and memory impairment induced by ALCL3 than each one alone. Th ey signifi cantly increased both swimming and climbing score as well as time spent in the correct quadrant, while signifi cantly decrease number of learning trials. Caff eine and nicotine co-administration also prevent neuronal degeneration in the hippocampus and the eosinophilic plagues in the striatum induced by ALCL3 while nicotine alone still showed mild gliosis in striatum. Th e marked protection of caff eine and nicotine co-administration confi rmed also by the signifi cant increase in TAC and SOD and decrease in MDA and ACHE in brain tissue. In conclusion, co-administration of caff eine and nicotine can reduce the risk of neuronal degeneration in the hippocampus and attenuate the impairment of learning and memory associated with AD.
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 16 May 2016
The Potential Effect of Caffeine and Nicotine Co-administration against Aluminum-induced Alzheimer's disease in Rats
Conference abstract · 2019
The influence of caffeine and nicotine co-administration in enhancing the power of physical activity against aluminum-induced Alzheimer’s disease in rats
Conference abstract · 29 Nov 2017
Galantamine potentiates neuroprotective potential of Taurine in AÃ?² (1-42) induced animal model of Alzheimer′s disease: The synergistic role of GABAA & Ã?± 7 nicotinic acetylcholine receptors
Conference abstract · 18 Mar 2019
Study the effect of Metformin drug on the abundance of alpha -7 nicotinic acetylcholine receptors (α7-nAChRs) at induced mice diabetic disease tissues and its relation to the incident of Alzheimer disease
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Azza A Ali”
